$CGBD

Carlyle Secured Lending, Inc. (CGBD) Q2 Earnings and Revenues Surpass Estimates

Carlyle Secured Lending, Inc. (CGBD) reported Q2 adjusted EPS of $0.35, above the Zacks Consensus of $0.32, and revenues of $40.8 million, above the $38.4 million estimate. EPS was $0.39 a year earlier. For the coming quarter, consensus calls for EPS of $0.33 on $39.86 million revenue.

Original reporting
Published Aug 7, 2026, 2:35 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Carlyle Secured Lending, Inc. (CGBD) Q2 Earnings and Revenues Surpass Estimates — source image
Decision brief

The 30-second read

$CGBDBullishMed
01

Why it matters

Traders can use the reported EPS and revenue beats as a near-term catalyst, but the actionable driver is whether management commentary changes the consensus trajectory for the coming quarter(s) and fiscal year.

02

Market read

A reported EPS and revenue beat provides a fresh earnings catalyst, but the article does not include new forward guidance, so follow-through depends on the earnings call and subsequent estimate revisions.

03

What to watch

The article flags that immediate price movement depends on management commentary, but it does not disclose that commentary or any updated guidance, leaving a key driver unquantified.

Relevance 7/10Novelty 6/10Timing: post-earnings release, ahead of earnings-call commentary and estimate revisions

Background

The article summarizes Carlyle Secured Lending’s Q2 results versus Zacks Consensus and discusses the role of earnings estimate revisions and the Zacks Rank.

Company-level read

Ticker impact

$CGBDBullishMedium confidence
Context

Carlyle Secured Lending reported Q2 EPS of $0.35 vs $0.32 consensus and revenues of $40.8M vs $38.4M estimate.

Expected impact

Likely modest positive bias initially, with direction dependent on the earnings-call outlook and any changes to near-term consensus.

Evidence & confidence

The article provides the surprise magnitudes and notes the stock’s near-term path depends on management commentary and estimate revisions, but it does not include guidance or a new forward datapoint beyond consensus figures.

Market effects

As an SBIC/commercial lender, the print can influence sentiment toward small-cap structured credit and SBIC peers, though the article provides no sector-wide catalyst.

No regional-specific impact described.

No global macro or cross-border linkage described.

Counterpoint

Despite the beat, revenues declined year over year ($45.55M to $40.8M), so the market may focus on deterioration rather than the quarter’s relative outperformance.

Key entities

  • Carlyle Secured Lending, Inc.

    SBIC/commercial lender reporting Q2 EPS and revenue beats versus consensus, with near-term outlook tied to earnings-call commentary.

  • Zacks Consensus Estimate

    Street benchmark used to quantify the EPS and revenue surprises reported in the article.

  • Zacks Rank #3 (Hold)

    The article states the stock’s Zacks Rank is Hold ahead of the earnings release, implying expectations are roughly in line.

Related articles

$CGBDMed

Carlyle Secured Lending Reports $2.4B Investment Value

Carlyle Secured Lending (NASDAQ: CGBD) reported Q2 2026 results for the quarter ended June 30, 2026. Net investment income and adjusted net investment income were $0.35 per common share. NAV per share fell 1.8% to $15.61, while total fair value of investments rose to $2.4 billion. The board declared a $0.35 Q3 2026 dividend payable Oct. 16, 2026.

$CGBDMed

Carlyle Secured Lending, Inc. (CGBD): Results of Operations and Financial Condition

Carlyle Secured Lending, Inc. (CGBD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 cgbd_ex992.htm EX-99.2 cgbd_ex992 Carlyle Secured Lending, Inc. (“CGBD”) Quarterly Earnings Presentation June 30, 2026 Plum R117 G45 B79 Dark Gray R101 G101 B101 Light Green R216 G240 B221 Pale Blue R221 G244 B255 Light Indigo R176 G188 B228 Indigo R49 G71 B143 Brown R9

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.